Lab automation has moved from a luxury for big pharma to a practical necessity for almost any lab running meaningful throughput. Liquid handling robots prepare libraries, set up reactions, and run assays with a consistency no human can match, and the market now spans everything from six-figure industrial workstations to accessible benchtop systems a startup can actually afford. Here is a guide to the leading companies and how to choose.
How to think about the market
The single most useful thing to understand is that automation is not one category but a spectrum, and the right system depends far more on your throughput, budget, and workflows than on which brand is most prestigious. At one end sit high-throughput industrial platforms built for speed and volume in screening and production environments. At the other sit accessible, flexible benchtop robots that bring automation within reach of academic labs and startups. In between are versatile workstations that handle complex multi-stage protocols. Buying more automation than your workflows justify is a common and expensive mistake, as is buying a system that cannot grow with you.
The established leaders
- Hamilton is widely regarded as the high-end standard for speed and precision, with its Microlab STAR line dominating high-throughput, high-volume applications where reliability under heavy load is paramount.
- Tecan is the other major force in liquid handling and automation, with platforms like Fluent and the long-established EVO line deployed across pharma, biotech, and diagnostics.
- Beckman Coulter (part of Danaher) offers highly configurable systems, notably the Biomek line, valued for versatility across complex, multi-stage protocols, and it also owns acoustic dispensing technology for very low volumes.
- Thermo Fisher, Agilent, and Revvity (formerly PerkinElmer) all bring broad automation portfolios integrated with their wider instrument ecosystems, which matters if you want one vendor across detection, handling, and analysis.
- Eppendorf is a reliable choice for compact, user-friendly benchtop workstations handling routine PCR setup and nucleic acid purification.
The accessible and specialized challengers
The most interesting development of recent years is how far the entry price has fallen.
- Opentrons has done more than anyone to lower the barrier, offering open-source, modular, affordable systems that let academic labs and startups automate work that previously had to be done by hand. Its newer platforms emphasize quick reconfiguration and no-code setup, and an active community protocol library reduces the learning curve substantially.
- SPT Labtech has built strong genomics-focused platforms that combine pipetting and dispensing to attack the specific bottlenecks in sequencing library preparation.
- INTEGRA Biosciences, Gilson, Formulatrix, Hudson Robotics, and Dynamic Devices serve a range of specialized and mid-range needs, and Automata and HighRes Biosolutions focus on integrated, walk-away workcells that chain instruments together.
What is changing
Two trends matter. First, no-code and simplified programming is spreading, letting scientists set up runs through touchscreens and visual interfaces rather than writing scripts, which dramatically widens who can actually use automation. Second, AI and integrated orchestration are moving in, with software layers that coordinate multiple instruments, manage samples, and increasingly apply machine learning to optimize workflows, pushing toward the long-promised idea of the self-driving lab. Together these are making automation less about buying a robot and more about building an integrated, software-managed workflow.
How to choose
Start with your actual workflows and throughput, not aspiration, since the most common error is over-buying. Consider the protocols you need and whether a system genuinely supports them, ideally verified with your own samples. Weigh flexibility versus speed: open, reconfigurable systems suit labs developing novel protocols, while high-throughput platforms suit labs running the same assay at volume. Assess integration with your existing instruments and informatics, since an island of automation creates as many problems as it solves. Factor in support, training, and service, which matter enormously when a robot goes down mid-run. And be realistic about total cost, including consumables, service contracts, and the staff time to develop and maintain methods.
The bottom line
Lab automation in 2026 spans a genuine spectrum, from Hamilton and Tecan at the high-throughput end, through versatile workstations from Beckman, Thermo Fisher, Agilent, and Eppendorf, to accessible open systems from Opentrons and genomics-focused platforms from SPT Labtech. The right choice follows from your workflows, throughput, budget, and technical resources, not from brand prestige. Match the system honestly to what your lab actually does, insist on seeing it run your protocols, and weigh support and integration heavily, and automation becomes the productivity multiplier it promises to be rather than an expensive machine gathering dust.
Automation fails for human reasons, not technical ones
The most common way lab automation disappoints is not that the robot cannot do the job, but that the lab never fully adopts it, and understanding this failure mode is worth as much as any purchasing criterion. Automation projects stall for predictable human and organizational reasons. Method development is underestimated: getting an automated protocol to work reliably with your specific samples, reagents, and plasticware takes real effort and expertise, and labs that budget for the instrument but not for the weeks of method development are routinely disappointed. Expertise walks out the door: if one person develops all the methods and understands the system, their departure can strand the instrument, so building shared knowledge and documentation matters. Training is skipped, leaving scientists who do not trust the system and quietly revert to doing things by hand. And the workflows around the robot are not redesigned, so the automation sits inside a process that still has manual bottlenecks upstream and downstream, delivering far less benefit than expected. The labs that get real value treat automation as a project rather than a purchase: they allocate genuine time for method development, train broadly rather than narrowly, document what they build, redesign the surrounding workflow, and start with a well-defined, high-value protocol rather than trying to automate everything at once. Do that, and automation delivers the consistency and throughput it promises. Skip it, and you own an expensive instrument that everyone works around, which is a depressingly common outcome and entirely avoidable.
A note on this snapshot
Lab automation is a broad and fast-moving field, and the companies named here are a starting point rather than a comprehensive list. New entrants continue to lower costs and simplify interfaces, and the software layer that orchestrates instruments is evolving quickly. Whatever you are considering, the enduring advice holds: match the system to your real workflows, insist on a demonstration with your own protocols and samples, weigh service and support heavily, and budget honestly for the method development that makes automation actually work.
Start with one workflow
The most reliable way to succeed with automation is to start narrow. Pick a single, well-defined, high-value protocol that your lab runs often, automate that properly, prove it works, and build from there. Labs that try to automate everything at once dilute their effort, hit multiple problems simultaneously, and often abandon the project. Labs that nail one workflow build confidence, expertise, and internal advocates, and the second and third protocols come far more easily. Momentum matters more than ambition in automation, and a single working method is worth more than an elaborate plan that never quite gets finished.
Buy for the workflow you have
The most expensive automation mistake is buying for the lab you hope to become rather than the lab you are. Aspirational purchases sit underused, their capacity idle and their complexity a burden, while the actual bottleneck in your workflow remains unaddressed. Identify the specific step that constrains your throughput today, automate that, and let demonstrated need drive the next purchase. Automation that solves a real, current bottleneck pays for itself; automation bought for a future that has not yet arrived usually just depreciates.
For the full, maintained list of lab equipment and life-science tools suppliers, browse the BioMed Nexus lab equipment and tools directory, and see our guides on choosing a lab equipment supplier and the tools companies that power every lab.
Frequently asked questions
What are the top lab automation companies?
Hamilton is widely regarded as the high-end standard for speed and precision, with Tecan the other major force in liquid handling. Beckman Coulter offers highly configurable Biomek systems, while Thermo Fisher, Agilent, Revvity and Eppendorf bring broad portfolios. Opentrons has made automation far more accessible with open-source, affordable systems, and SPT Labtech leads in genomics workflows.
What is the best liquid handling robot for a small lab?
Opentrons has done the most to lower the barrier for smaller labs, offering open-source, modular, affordable systems with no-code setup and a community protocol library that reduces the learning curve. Eppendorf's compact benchtop workstations are also a reliable choice for routine PCR setup and nucleic acid purification without a large budget.
How do I choose a lab automation system?
Start with your actual workflows and throughput rather than aspiration, since over-buying is the most common mistake. Verify the system genuinely supports your protocols, ideally with your own samples. Weigh flexibility versus raw speed, assess integration with existing instruments and informatics, factor in support and service, and account for total cost including consumables and staff time.
